Sarepta Therapeutics (SRPT) U.K.-Specific Hold Concerns 'Overblown' - William Blair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Form SC 13G/A Sarepta Therapeutics, Filed by: SUSQUEHANNA SECURITIES
February 9, 2018 11:41 AM EST
SECURITIES AND EXCHANGE COMMISSION
... MoreForm SC 13G Sarepta Therapeutics, Filed by: FMR LLC
February 9, 2018 9:46 AM ESTSCHEDULE 13G Amendment No. 0 SAREPTA THERAPEUTICS INC COMMON STOCK Cusip #803607100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #803607100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,870,066 Item 6: 0 Item 7: 5,568,006 Item 8: 0 Item 9: 5,568,006 Item 11: 8.604% Item 12: HC Cusip #803607100 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,568,006 Item 8: 0 Item 9: 5,568,006 Item 11: 8.604% Item 12: IN Item 1(a). Name of Issuer: SAREPTA THERAPEUTICS INC Item 1(b). Address of Issuer's Principal Executive Offices: 215 FIRST STREET SUITE 415 CAMBRIDGE, MA 02142... More
